Renal Cell Carcinoma News

• Signature Predicts Metastatic Survival in Clear Cell RCC The study, published as a preprint and not yet peer reviewed, identifies potential therapeutic targets to be further evaluated in preclinical models.
  First Look, August 31, 2022
• Men at Higher Risk Than Women for Many Cancers: Why? Men have significantly higher rates of several cancers at sites shared with women, but why is unclear. A new analysis finds that nonbiological risk factors explained only some of the difference.
  Medscape Medical News, August 11, 2022
• Treatment Combo Shows 'Clinical Benefit' in Liver Cancer Trial The combination of a tyrosine kinase inhibitor with an immune checkpoint inhibitor significantly improved progression-free survival in patients with hepatocellular carcinoma, shows a new study.
  MDedge News, August 05, 2022
• Targeted Therapy for Kidney Cancer Linked to Higher Cardiac Risk Patients on targeted therapy were more likely to develop conditions such as heart attacks and stroke than were those who took cytokine therapy.
  MDedge News, August 03, 2022
• Analysis Shows No Benefit for Cytoreductive Nephrectomy For patients with metastatic clear cell renal cell carcinoma, removing the kidney and its primary tumor is not associated with improved overall survival, a new analysis concludes.
  Medscape Medical News, July 19, 2022
• New Pelvic Tumor Radiation Regimen Safe, Effective for Palliation The regimen splits the difference between more conventional approaches. The study was published as a preprint and has not yet been peer reviewed.
  First Look, July 15, 2022
• Immunotherapy Combos Up Survival in Renal Cell Carcinoma In the absence of head-to-head trials, the findings help validate the applicability of phase 3 results to routine care. The study was published as a preprint and has not yet been peer reviewed.
  First Look, July 01, 2022
• ASCO 2022 Acetaminophen Linked to Diminished Response to Immunotherapy in Cancer The commonly used pain killer was strongly associated with a diminished response to immune checkpoint inhibitors in a study of 600 patients with cancer.
  Medscape Medical News, June 08, 2022
• AUA 2022 AUA 2022: A Report From the Trenches Colorado urologist Henry M. Rosevear, MD, offers his take on the scientific highlights of this year's annual meeting of the American Urological Association.
  Medscape Medical News, May 19, 2022
• Doctor Accused of 'Fraudulent Concealment' Can't Be Held Liable Claim against hospital is halted as well.
  Medscape Business of Medicine, May 18, 2022
• Same-Day Discharge After Robot-Assisted Partial Nephrectomy May Be Feasible in Some Patients In selected patients undergoing robot-assisted partial nephrectomy (RAPN), same-day discharge is feasible, a small study suggests.
  Reuters Health Information, April 29, 2022
• Combination Sitravatinib and Nivolumab Boosts Outcomes in Advanced Kidney Cancer In patients with advanced clear cell renal cell carcinoma, an optimal sitravatinib dose combined with a fixed dose of nivolumab improved outcomes in a phase 1-2 trial.
  Reuters Health Information, April 27, 2022
• PD-L1 Test Debated in Gastroesophageal Cancer Immunotherapy Clinicians are wondering whether measuring programmed death–ligand 1 (PD-L1) is essential before prescribing checkpoint inhibitors for gastroesophageal cancer.
  Medscape Medical News, April 20, 2022
• Injectable Gel Delivers Immune Cells Directly to Cancer Tumors Stanford University engineers created a new delivery method that may enhance CAR T-cell therapy by targeting solid tumors such as breast cancer.
  Medscape Medical News, April 14, 2022
• More Leisure Activity Reduces Risk of Obesity-related Cancers This risk reduction held regardless of a person's weight but appeared most pronounced for those with low-to-normal BMIs.
  Medscape Medical News, April 13, 2022
• Vitiligo From Checkpoint Inhibitors Not Limited to Melanoma Vitiligo can occur in any type of cancer, according to a new study published as a preprint and that has not yet peer reviewed.
  First Look, February 15, 2022
• City of Hope Spinoff Offers Remote Second Opinions An early study showed that significant changes to treatment plans were recommended for more than one quarter of patients with lung cancer.
  Medscape Medical News, December 23, 2021
• Using Renal Scoring Criteria May Spare Children's Kidneys Applying renal scoring criteria to children with kidney masses may help identify some who can be offered nephron-sparing surgery, instead of a radical nephrectomy, which is the standard of care.
  Medscape Medical News, December 21, 2021
• New Trials in Urologic Cancers: Could Your Patient Benefit? Maybe one of your patients could benefit from late-phase clinical trials that are currently recruiting patients with nonprostate urologic cancers.
  Medscape Medical News, December 13, 2021
• Physicians May Be Overprescribing Immunotherapy Many cancer patients who are ineligible for immunotherapy trials because of advanced disease or organ dysfunction are still receiving these drugs outside of trials, according to a new study.
  Medscape Medical News, December 08, 2021